comprehensive
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Rise in cancer among younger people worries and puzzles doctors
Next article: Rise in cancer among younger people worries and puzzles doctors
leisure time
entertainment
-
Biotech stock slump in 2023: awaiting the turnaround
2025-10-02 22:22 -
Biogen says it will cut costs by $700 million, slash 1,000 jobs
2025-10-02 21:21 -
Biotech stock slump in 2023: awaiting the turnaround
2025-10-02 21:06 -
Why are Kaiser Permanente staff considering a strike?
2025-10-02 20:25 -
CommonSpirit Health keeps growing, even as it loses money
2025-10-02 20:01 -
STAT Virtual Event: Putting AI to the Test
2025-10-02 19:58